Clinical Trial

Study of Intra-articular Allocetra in Knee Osteoarthritis

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This is a double blind, randomized,multi-center study to evaluate the safety and efficacy of intra-articular administration of Allocetra compared to placebo in patients with symptomatic knee osteoarthritis.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2024-01-22; most recent amendment 2026-04-26.
Status change: Recruiting → Active, Not Recruiting 2025-04-22
Status change: Not Yet Recruiting → Recruiting 2024-02-07
Trial Details
NCT Number NCT06233474
Lead Sponsor Enlivex Therapeutics Ltd.
Collaborators: Nordic Bioscience Clinical Development (NBCD)
Conditions Osteoarthritis, Knee
Enrollment 160 participants
Start Date 2024-01-26
Primary Completion 2026-03-15 (estimated)
Study Completion 2026-05-15 (estimated)
Updated on ClinicalTrials.gov 2026-04-30